

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 160/4,5mcg | 6 inhaler | NZD132.53 | NZD935.50 NZD795.17 Best Price Popular | |
| 160/4,5mcg | 3 inhaler | NZD144.58 | NZD510.26 NZD433.72 | |
| 160/4,5mcg | 1 inhaler | NZD168.65 | NZD198.42 NZD168.65 |
The combination medication containing Budesonide and Formoterol Fumarate Dihydrate is commonly prescribed for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This medication offers a dual approach by providing both anti-inflammatory effects and bronchodilation, making it an effective treatment option for many patients. The synergy of these two active ingredients helps improve lung function and reduce symptoms like wheezing, coughing, and shortness of breath.
Budesonide is a corticosteroid that works by decreasing inflammation in the airways. It reduces swelling and mucus production, helping to prevent asthma attacks and exacerbations. Formoterol Fumarate Dihydrate, on the other hand, is a long-acting beta-agonist (LABA) that relaxes the muscles around the airways, allowing for easier airflow. When combined, these two compounds provide a comprehensive approach to managing airway inflammation and bronchoconstriction.
Patients using Budesonide / Formoterol Fumarate Dihydrate often experience significant improvements in their breathing capacity and symptom control. The dual action can lead to fewer exacerbations and a reduced need for rescue inhalers. This medication is particularly beneficial for individuals with moderate to severe asthma or COPD, where controlling symptoms is essential for maintaining a normal quality of life.
Moreover, this combination therapy simplifies treatment regimens by combining two powerful agents into a single inhaler. This can improve adherence, ensuring consistent medication use and better overall outcomes. Patients often report feeling more energetic and able to participate in daily activities without frequent respiratory interruptions.
It is important to follow the prescribed dosage and inhalation instructions carefully. Typically, the medication is administered via inhaler, with doses personalized by a healthcare professional based on the patientβs condition. Regular use, even when feeling well, is crucial for optimal control of respiratory symptoms. Patients are advised to rinse their mouth after inhalation to prevent irritation and oral thrush, a common side effect of inhaled corticosteroids.
Like all medications, Budesonide / Formoterol Fumarate Dihydrate can cause side effects. Some common reactions include throat irritation, cough, headache, and hoarseness. More serious but less frequent issues may involve increased heart rate, tremors, or allergic reactions. It is essential for patients to report any unusual symptoms to their healthcare providers promptly.
It should be used with caution in individuals with certain health conditions, such as heart disease or sensitivities to components of the drug. Pregnant or breastfeeding women should consult a doctor before starting treatment to assess potential risks and benefits.
The combination of Budesonide and Formoterol Fumarate Dihydrate remains a cornerstone in respiratory therapy. Its ability to provide both anti-inflammatory and bronchodilatory effects makes it a valuable tool in managing persistent respiratory conditions. Proper use and regular medical supervision are key to maximizing its benefits and minimizing potential side effects. Patients who adhere to their prescribed treatment plan often experience a noticeable improvement in their breathing and overall respiratory health.
14β21 days. Free from NZD347.22 .
5β9 days. NZD52.08
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.